16The signalling pathways initiated by members of the transforming growth factor-β (TGFβ) 17 family of cytokines control many metazoan cellular processes, including proliferation and 18 differentiation, epithelial-mesenchymal transition (EMT), and apoptosis. TGFβ signalling is 19 therefore strictly regulated to ensure appropriate context-dependent physiological 20 responses. In an attempt to identify novel regulatory components of the TGFβ signalling 21 pathway, we performed a pharmacological screen using a cell line engineered to report the 22 endogenous transcription of the TGFβ-responsive target gene PAI-1. The screen revealed 23 that small-molecular inhibitors of salt-inducible kinases (SIKs) attenuate TGFβ-mediated 24 transcription of PAI-1 without affecting receptor-mediated SMAD phosphorylation, SMAD 25 complex formation or nuclear translocation. We provide evidence that genetic inactivation 26 of SIK isoforms also attenuates TGFβ-dependent transcriptional responses. Pharmacological 27 inhibition of SIKs using multiple small-molecule inhibitors potentiated apoptotic cell death 28 induced by TGFβ stimulation. Our data therefore provides evidence for a novel function of 29 SIKs in modulating TGFβ-mediated transcriptional and cellular responses. 30 31 Previously, we developed an endogenous transcriptional reporter cell line for the TGFβ 62 pathway using CRISPR-Cas9 genome editing technology 21 by inserting firefly (Photinus 63 pyralis) luciferase and green fluorescent protein (GFP) at the native TGFβ-responsive target 64 gene plasminogen activator inhibitor 1 (PAI-1) locus ( Figure 1A). The transcription of PAI-1 is 65 induced in response to TGFβ signals in different cell types in a SMAD-dependent 66 manner 22,23 . Moreover, the promoter region of the endogenous PAI-1 gene has been 67 frequently utilised in order to generate conventional luciferase-based overexpression 68 reporter systems for the study of TGFβ-mediated transcriptional regulation 24 . In order to 69 identify novel regulatory components of the TGFβ pathway, we performed a 70 pharmacological screen in this endogenous TGFβ-responsive transcriptional reporter cell 71 line using a panel of small-molecules obtained from the MRC International Centre for Kinase 72 Profiling at the University of Dundee. The panel consisted predominantly of selective and 73 potent inhibitors of protein kinases but also included a small number of compounds which 74 target components of the ubiquitin-proteasome system (UPS). The screen identified salt-75 inducible kinases (SIKs), which are members of the AMPK-activated protein kinase (AMPK)-76 related subfamily of serine-threonine specific kinases 25,26 , as potential novel regulators of 77 TGFβ-mediated gene transcription. In this study, we have therefore investigated the role of 78 SIKs in regulating the TGFβ signalling pathway. 79 80 Results 81
Identification of salt-inducible kinases (SIKs) as novel regulators of TGFβ-mediated gene 82 transcription 83We tested the utility of the endogenous TGFβ-responsive transcript...